新鲜与冻融周期后521例妊娠的围产结局:比较GnRH拮抗剂与激动剂方案的随机对照试验次要结局
该研究为一项IV期双中心开放标签随机对照试验的次要结局分析,纳入1050例<40岁首次接受辅助生殖技术治疗的女性,比较GnRH拮抗剂与长方案GnRH激动剂后的围产结局。共分析521例妊娠,结果显示两种方案的新鲜胚胎移植后单胎活产的早产、低出生体重等围产结局相似,冻融周期后亦相似。作者认为选择GnRH类似物应仅基于优化妊娠机会,而非围产结局风险。
要点
- GnRH拮抗剂与激动剂方案的新鲜胚胎移植后单胎活产围产结局相似。
- 冻融胚胎移植周期后两种方案的围产结局亦相似。
- 作者认为选择GnRH类似物应仅基于优化妊娠机会而非围产结局风险。
核心结论
- GnRH拮抗剂与GnRH激动剂方案IVF后的围产结局相似。
- 作者认为选择GnRH类似物应仅基于优化妊娠机会,而非围产结局风险。
研究设计与样本
- IV期、双中心、开放标签、随机对照试验的次要结局分析。
- 纳入1050例<40岁首次接受辅助生殖技术治疗的女性,按1:1随机分组,2009年1月至2013年12月随机,随访至2016年12月。
- 分析单次取卵后所有新鲜和冻融胚胎移植周期中形成妊娠(hCG>10 IU/l)的521例。
主要发现
- 新鲜胚胎移植后单胎活产中,平均分娩孕周拮抗剂组39.1±2.49周 vs 激动剂组39.3±1.90周(P=0.67)。
- 极早产率拮抗剂组1.9% vs 激动剂组0%(P=0.17)。
- 平均出生体重拮抗剂组3264±662 g vs 激动剂组3341±562 g(P=0.37)。
- 低出生体重率拮抗剂组12.4% vs 激动剂组7%(P=0.19),极低出生体重率2.9% vs 1%(P=0.34)。
- 冻融胚胎移植周期后围产结局相似;新鲜和冻融周期后单胎活产小于胎龄儿和大于胎龄儿率在两种方案中相似。
临床怎么用
- 作者认为选择GnRH类似物应仅基于优化妊娠机会,而非围产结局风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Are perinatal outcomes different after treatment with the gonadotrophin-releasing hormone (GnRH) antagonist versus the long GnRH agonist protocol for IVF? DESIGN: Perinatal outcomes were secondary outcomes in a large Phase IV, dual-centre, open-label, randomized controlled trial to compare GnRH antagonist and long GnRH agonist protocols in women <40 years undergoing their first assisted reproductive technology treatment. Women (n = 1050) were randomized in a ratio 1:1 from January 2009 to December 2013 and followed until December 2016. All fresh and frozen embryo transfer (FET) cycles from a single oocyte aspiration, resulting in a gestation (human chorionic gonadotrophin >10 IU/l) were included (n = 521). Data were analysed to compare preterm birth [PTB] (<37 weeks), very PTB (<32 weeks), low birthweight [LBW] (<2500 g) and very LBW (<1500 g) rates among singleton live births in GnRH antagonist versus agonist protocol. RESULTS: Similar perinatal outcomes were found after both protocols. In singletons after fresh embryo transfer, mean gestational age at delivery was 39.1 ± 2.49 versus 39.3 ± 1.90 (P = 0.67) and very PTB rates 1.9% versus 0% (P = 0.17). Mean birthweight was 3264 ± 662 g in the antagonist and 3341 ± 562 g in the agonist group (P = 0.37). LBW was found in 12.4% versus 7% (P = 0.19) and very LBW in 2.9% versus 1% (P = 0.34). In FET cycles, the perinatal outcomes were similar. Small for gestational age and large for gestational age rates were similar in both protocols for singleton live births after fresh and FET. CONCLUSIONS: Perinatal outcomes are similar after the GnRH antagonist versus GnRH agonist protocols for IVF. The choice of the GnRH analogue in ovarian stimulation should be based solely on optimizing the chance of pregnancy and not on risks in perinatal outcomes.
引用
- Tomás C, Toftager M, Løssl K, et al. Perinatal outcomes in 521 gestations after fresh and frozen cycles: a secondary outcome of a randomized controlled trial comparing GnRH antagonist versus GnRH agonist protocols. Reprod Biomed Online. 2019. PMID: 31409522. doi:10.1016/j.rbmo.2019.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。